The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma

Ann Oncol. 2016 Jun;27(6):1174-1177. doi: 10.1093/annonc/mdw056. Epub 2016 Feb 9.

¹ Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Systems Biology & Personalized Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Melbourne; Department of Medicine, University of Melbourne, Melbourne, Australia.
² Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne.
³ Cancer Immunology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne; Department of Pathology, University of Melbourne, Parkville.
⁴ Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre, Melbourne; Department of Pathology, University of Melbourne, Parkville.
⁵ Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Molecular Oncology Laboratory, Oncogenic Signalling and Growth Control Program; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne; Department of Pathology, University of Melbourne, Parkville; Department of Medicine, University of Melbourne, Melbourne, Australia.
⁶ Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne; Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne; Department of Medicine, University of Melbourne, Melbourne, Australia. Electronic address: shahneen.sandhu@petermac.org.

No abstract available

Publication types